Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Atropine sulfate
Drug ID BADD_D00190
Description An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae.
Indications and Usage For the treatment of poisoning by susceptible organophosphorous nerve agents having anti-cholinesterase activity (cholinesterase inhibitors) as well as organophosphorous or carbamate insecticides.
Marketing Status Prescription; Discontinued
ATC Code A03BA01; S01FA01
DrugBank ID DB00572
KEGG ID D02069
MeSH ID D001285
PubChem ID 60196398
TTD Drug ID D0RG3O
NDC Product Code 51662-1509; 51662-1527; 0404-9823; 0404-9822; 13985-606; 52584-630; 0409-1630; 51552-1391; 0641-6006; 50268-118; 71872-7100; 70518-3120; 38779-2267; 71872-7037; 52584-002; 76329-3340; 51662-1339; 50090-4524; 51662-1311; 0404-9820; 52584-401; 63323-580; 50090-5924; 16729-512; 0409-4910; 50090-3138; 0409-4911; 16729-483; 52584-910; 0404-9821; 71872-7255; 0404-9824; 52584-029; 13371-387; 63827-1014; 71872-7002; 69205-736; 71872-7001; 71872-7245; 0517-1010; 0641-6251; 0404-9819; 16729-484; 76329-3339; 0409-9630; 16729-526; 43235-0004; 51662-1378; 51662-1289; 50090-3104; 52584-044; 51662-1207; 12714-031; 42385-736; 17478-215; 71684-0303; 70121-1705; 0517-0401; 62991-2842; 60505-6226; 62068-306; 52221-107; 55742-124; 76003-0157; 51662-1208; 71872-7246; 69205-031; 16729-525; 71872-7017; 0065-0303; 71872-7252; 24208-825; 51927-0156
Synonyms Atropine | Atropinol | Atropine Sulfate | Sulfate, Atropine | Atropine Sulfate Anhydrous | Anhydrous, Atropine Sulfate | Sulfate Anhydrous, Atropine | AtroPen | Atropin Augenöl | Augenöl, Atropin
Chemical Information
Molecular Formula C34H48N2O10S
CAS Registry Number 55-48-1
SMILES CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(= O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Atrial fibrillationNot AvailableF1PE02Not AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash scarlatiniform23.03.13.006--Not Available
Red blood cell count increased13.01.05.008--Not Available
Respiration abnormal22.02.08.011--Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Restlessness17.02.05.021; 19.11.02.002--
Salivary hypersecretion07.06.01.009--Not Available
Seizure17.12.03.001--
Sinus tachycardia02.03.03.010--
Skin discolouration23.03.03.005--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin warm23.03.03.014--Not Available
Somnolence17.02.04.006; 19.02.05.003--
Strabismus17.17.01.009; 06.05.02.004--Not Available
Stridor22.04.02.003--
Stupor17.02.04.007; 19.02.05.004--Not Available
Supraventricular extrasystoles02.03.03.011--Not Available
Supraventricular tachycardia02.03.03.012--
Syncope02.01.02.008; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.014--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Tremor17.01.06.002--
Urinary hesitation20.02.02.009--Not Available
Urinary retention20.02.02.011--
Ventricular arrhythmia02.03.04.006--
Ventricular extrasystoles02.03.04.007--Not Available
Ventricular fibrillation02.03.04.008--
Ventricular flutter02.03.04.009--Not Available
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.003--
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages